[{"label":"Home","url":"https:\/\/www.pbo-dpb.ca\/en"},{"label":"Resources","url":"https:\/\/www.pbo-dpb.ca\/en\/resources--ressources"},{"label":"Bills","url":"https:\/\/www.pbo-dpb.ca\/en\/bills--projets-de-loi"},{"label":"45-1","url":"https:\/\/www.pbo-dpb.ca\/en\/bills--projets-de-loi\/45-1"},{"label":"An Act respecting a national framework on sickle cell disease","url":"https:\/\/www.pbo-dpb.ca\/en\/bills--projets-de-loi\/45-1\/S-201"}]
Bill S-201 (45-1)

An Act respecting a national framework on sickle cell disease

Open on LEGISinfo
{"id":"ES-2627-005-M","is_published":"2026-11-03T13:57:03.000000Z","release_date":"2026-11-03T14:00:00.000000Z","last_revised_date":null,"title_en":"Cost estimate for a national framework on sickle cell disease","title_fr":"Estimation des co\u00fbts d\u2019un cadre national sur la maladie falciforme","internal_id":"ES-2627-005-M","metadata":{"abstract_en":"At the request of Member of Parliament Dan Mazier, the Parliamentary Budget Office (PBO) estimated the fiscal cost of Bill S-201, *An Act respecting a national framework on sickle cell disease*.","abstract_fr":"\u00c0 la demande du d\u00e9put\u00e9 Dan Mazier, le Bureau de la directrice parlementaire du budget (BDPB) a \u00e9valu\u00e9 le co\u00fbt financier du projet de loi S-201, *Loi concernant un cadre national sur la maladie falciforme*.","highlights":[{"content":{"en":"The Parliamentary Budget Office (PBO) estimates that implementing and administering Bill S-201 could cost $20.1 million over the five-year period spanning 2026-27 to 2030-31.","fr":"Le Bureau de la directrice parlementaire du budget (BDPB) estime que la mise en \u0153uvre et l\u2019administration du projet de loi S-201 pourraient co\u00fbter 20,1 millions de dollars sur la p\u00e9riode de cinq ans allant de 2026-\u00ad2027 \u00e0 2030-2031."}},{"content":{"en":"The estimate reflects costs associated with the activities contemplated in Bill S-201, An Act respecting a national framework on sickle cell disease, including a national research network, a patient registry, stakeholder engagement, development of national standards, analyses, and administrative activities. It does not include potential future measures, programs, or services that could arise from the framework\u0027s recommendations.","fr":"L\u2019estimation refl\u00e8te les co\u00fbts associ\u00e9s aux activit\u00e9s envisag\u00e9es dans le projet de loi S-\u00ad201, Loi concernant un cadre national sur la maladie falciforme, notamment en ce qui concerne un r\u00e9seau national de recherche, un registre des patients, la consultation des intervenants, l\u2019\u00e9tablissement de normes nationales, les analyses ainsi que les activit\u00e9s administratives. Elle ne tient pas compte des mesures, des programmes ou des services \u00e9ventuels qui pourraient d\u00e9couler des recommandations li\u00e9es au cadre."}},{"content":{"en":"Approximately 80 per cent of the estimated cost is attributable to three activities: the creation of a National Research Network (25% of costs), the establishment of a National Patient Registry (25% of costs), and supporting public awareness campaigns to increase diversity in Canada\u2019s blood supply (30% of costs).","fr":"Environ 80 % des co\u00fbts estim\u00e9s sont attribuables \u00e0 trois activit\u00e9s : la cr\u00e9ation d\u2019un r\u00e9seau national de recherche (25 % des co\u00fbts), l\u2019\u00e9tablissement d\u2019un registre national des patients (25 % des co\u00fbts) et les mesures visant \u00e0 soutenir des campagnes publiques de sensibilisation afin d\u2019accro\u00eetre la diversit\u00e9 d\u2019une r\u00e9serve de sang du Canada (30 % des co\u00fbts)."}},{"content":{"en":"Actual implementation costs are uncertain and will ultimately depend on the scope of activities undertaken, as the bill does not prescribe specific funding levels or implementation approaches. Incremental costs could be lower if existing resources are used to support implementation or higher if implementation includes more activities than assumed in this estimate.","fr":"Les co\u00fbts r\u00e9els de mise en \u0153uvre sont incertains et d\u00e9pendront de la port\u00e9e des activit\u00e9s entreprises, le projet de loi ne prescrivant pas de niveaux de financement ni d\u2019approches de mise en \u0153uvre en particulier. Les co\u00fbts suppl\u00e9mentaires pourraient \u00eatre inf\u00e9rieurs si les ressources existantes sont utilis\u00e9es pour appuyer la mise en \u0153uvre, ou sup\u00e9rieurs si la mise en \u0153uvre inclut davantage d\u2019activit\u00e9s que ce que l\u2019on suppose dans cette estimation."}}]},"updated_at":"2026-11-03T13:57:03.000000Z","type":"ES","slug":"ES-2627-005-M--cost-estimate-national-framework-sickle-cell-disease--estimation-couts-un-cadre-national-maladie-falciforme","permalinks":{"en":{"website":"https:\/\/www.pbo-dpb.ca\/en\/publications\/ES-2627-005-M--cost-estimate-national-framework-sickle-cell-disease--estimation-couts-un-cadre-national-maladie-falciforme","preview":"https:\/\/www.pbo-dpb.ca\/en\/publications\/ES-2627-005-M--cost-estimate-national-framework-sickle-cell-disease--estimation-couts-un-cadre-national-maladie-falciforme"},"fr":{"website":"https:\/\/www.pbo-dpb.ca\/fr\/publications\/ES-2627-005-M--cost-estimate-national-framework-sickle-cell-disease--estimation-couts-un-cadre-national-maladie-falciforme","preview":"https:\/\/www.pbo-dpb.ca\/fr\/publications\/ES-2627-005-M--cost-estimate-national-framework-sickle-cell-disease--estimation-couts-un-cadre-national-maladie-falciforme"}},"artifacts":{"main":{"en":{"public":"https:\/\/distribution-a617274656661637473.pbo-dpb.ca\/af243ee0fead1ce1b2d6c6e930c668db8f0a8f0f8b02660b6dca01b9336572aa"},"fr":{"public":"https:\/\/distribution-a617274656661637473.pbo-dpb.ca\/0e80877e2c9761d313087c1e9b327831f553ee2d5889a886d09c80a9b5bb4364"}}},"coverpages":{"distribution":{"fr":{"small":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/9e64a720c2ef503cde507d8bf1821656a98771c1dc23edf24dea9da4c6a9d321","large":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/99e263bce956cd21283175c10a7d595b23e5ae125bbc536a4536611d9459a173","h150_png_optimized":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/c8294ba2d54411edb09f2ac09f252de6a4888277a176ce4657282ce75aeb9977","h150_webp":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/d372ea1c7adcd7234c9cf7cbd459e21fed3515b9f127437a06fed003e17f64a7","h300_png_optimized":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/ada90a67b72b34f75fed5bd725cd7b555353afe5abed6265961a7f80fa5e6d4a","h300_webp":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/9b47ee01728302eff2a9d5676ca662a09a53a103cc4b22fe64b7b6f65b8018e9","h600_png_optimized":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/972733e4d627e6972f100579aa2f8387973fc9eaaf5b3804725b159c9e8ce890","h600_webp":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/e21f1cdd4689e694058016cc22238ed074e8f240e44e694d2808cecc1f2067df"},"en":{"small":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/cb374f0dd926072a14d87b6be6c1163cb4010785027ef301298631efecb883d0","large":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/841b25f9c15539067181ce9087885ac0da4e199df304905851ab4ebf9331ceb7","h150_png_optimized":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/5240d420d7f499a851b3d241a81d29c326183240af3e135e01dfe106e6d121d0","h150_webp":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/2e463717590129029daf8755c5286adb653f8777ca19c8a79aadf1007c98e3d7","h300_png_optimized":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/79b2cfbf548d212f049b63a35c3cef694a5346bb757bca84ad06ade572eaec21","h300_webp":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/cef82f8dc435dc45664770f62dd641c663e998105129312d69b6d1a055ebfe6f","h600_png_optimized":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/9b45e0a03ead482c7fd292c98715eec91b4ff2b92f3beb435892c011e68ee900","h600_webp":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/03ff0ec91fe8b37895b4b34ca64501aadf05e9f38d3195dfbcdb46a360146f5d"}}},"bills":[{"id":616,"created_at":"2025-06-09T20:57:23-04:00","updated_at":"2026-11-03T08:57:09-05:00","legisid":"45_1_S-201","parliament":45,"session":1,"prefix":"S","number":201,"title_en":"An Act respecting a national framework on sickle cell disease","title_fr":"Loi concernant un cadre national sur la maladie falciforme","bill_num":"S-201","permalinks":{"en":{"website":"https:\/\/www.pbo-dpb.ca\/en\/bills--projets-de-loi\/45-1\/S-201","legisinfo":"https:\/\/www.parl.ca\/legisinfo\/en\/bill\/45-1\/s-201"},"fr":{"website":"https:\/\/www.pbo-dpb.ca\/fr\/bills--projets-de-loi\/45-1\/S-201","legisinfo":"https:\/\/www.parl.ca\/LegisInfo\/fr\/projet-de-loi\/45-1\/s-201"}},"pivot":{"publication_id":926,"bill_id":616}}],"labels":[],"bibtex":{"en":"@techreport{PBO-ES2627005M,\n author={Kho, Albert},\n title={Cost estimate for a national framework on sickle cell disease},\n institution={The Office of the Parliamentary Budget Officer},\n year=2026,\n \n address = \u0022Ottawa, ON\u0022\n}","fr":"@techreport{DPB-ES2627005M,\n author={Kho, Albert},\n title={Estimation des couts d\u2019un cadre national sur la maladie falciforme},\n institution={Bureau de la directrice parlementaire du budget},\n year=2026,\n \n address = \u0022Ottawa, ON\u0022\n}"}}